Dual roles of estrogen metabolism in mammary carcinogenesis

키워드

참고문헌 (110)

1. Beatson,G.T, "On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases", Lancet, 2, pp.104~107 (1896)
2. Simpson, E. R, "Sources of estrogen and their importance", J. Steroid Biochem. Mol. Biol, 86, pp.225~230 (2003)
3. Boukari, K, "Human fetal testis: source of estrogen and target of estrogen action", Hum. Reprod, 22, pp.1885~1892 (2007)
4. Colditz, G. A, "Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer", J. Natl. Cancer I, 90, pp.814~823 (1998)
5. Feigelson, H. S, "Estrogens and breast cancer", Carcinogenesis, 17, pp.2279~2284 (1996)
6. Xu, W. H, "Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai", Int. J. Cancer, 108, pp.613~619 (2004)
7. Kaaks, R, "Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)", J. Natl. Cancer Inst, 97, pp.755~765 (2005)
8. Zucchetto, A, "Hormone-related factors and gynecological conditions in relation to endometrial cancer risk", Eur. J. Cancer Prev, 18, pp.316~321 (2009)
9. Russo, J, "Developmental, cellular, and molecular basis of human breast cancer", J. Natl. Cancer Inst. Monogr, 27, pp.17~37 (2000)
10. Castagnetta, L, "Sex steroids, carcinogenesis, and cancer progression", Ann. N.Y. Acad. Sci, 1028, pp.233~246 (2004)
11. Bocchinfuso, W. P, "Mammary gland development and tumorigenesis in estrogen receptor knockout mice", J. Mal. Gland Biol. Neoplasia, 2, pp.323~334 (1997)
12. The National Toxicology Program (NTP), "Federal Report on Carcinogens", pp.177283~177285 (2002)
13. WHO, "Hormonal Contraception and Post-Menopausal Hormonal Therapy; in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans", pp.399~530 (1999), IARCPress
14. Yager, J. D, "Estrogen carcinogenesis in breast cancer", N. Engl. J. Med, 354, pp.270~282 (2006)
15. Russo, J, "The role of estrogen in the initiation of breast cancer", J. Steroid Biochem. Mol. Biol, 102, pp.89~96 (2006)
16. Sarabia, S. F, "Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens", Chem. Res. Toxicol, 10, pp.767~771 (1997)
17. Raftogianis, R, "Estrogen metabolism by conjugation", J. Natl. Cancer Inst. Monogr, 27, pp.113~124 (2000)
18. Hachey, D. L, "Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism", Cancer Res, 63, pp.8492~8499 (2003)
19. Yue, W, "Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis", J. Steroid Biochem. Mol. Biol, 86, pp.477~486 (2003)
20. Russo, J, "17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells", FASEB J, 20, pp.1622~1634 (2006)
21. Russo, J, "Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells", J. Steroid Biochem. Mol. Biol, 87, pp.1~25 (2003)
22. 장민선, "Unexpected Hormonal Activity of a Catechol Equine Estrogen Metabolite Reveals Reversible Glutathione Conjugation", CHEMICAL RESEARCH IN TOXICOLOGY, 23, pp.1374~1383, AMER CHEMICAL SOC
23. Schutze, N, "Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells", J. Steroid Biochem. Mol. Biol, 48, pp.453~461 (1994)
24. Zhu, B. T, "Functional role of estrogen metabolism in target cells: review and perspectives", Carcinogenesis, 19, pp.1~27 (1998)
25. Chang, M, "Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells", Endocrinology, 148, pp.4793~4802 (2007)
26. Tsutsui, T, "Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, an endogenous metabolite of estrogen", Carcinogenesis, 21, pp.735~740 (2000)
27. Sutherland, T. E, "2-Methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer", Clin. Cancer Res, 11, pp.1722~1732 (2005)
28. Parl, F. F, "Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction", Cancer Inform, 7, pp.109~121 (2009)
29. Crooke, P. S, "Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction", Cancer Epidemiol. Biomarkers Prev, 20, pp.1502~1515 (2011)
30. Williamson, D. G, "The biochemistry of the 17-hydroxysteroid dehydrogenases; in Steroid Biochemistry", pp.83~110 (1979), CRC Press
31. Suchar, L. A, "High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats", J. Pharmacol. Exp. Ther, 272, pp.197~206 (1995)
32. Liehr, J. G, "Carcinogenicity of catechol estrogens in Syrian hamsters", J. Steroid Biochem. Mol. Biol, 24, pp.353~356 (1986)
33. Li, J. J, "Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism", Fed. Proc, pp.1858~1863 (1987)
34. Newbold, R. R, "Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens", Cancer Res, 60, pp.235~237 (2000)
35. Li, K. M, "Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo", Carcinogenesis, 25, pp.289~297 (2004)
36. El-Bayoumy, K, "Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in the rat mammary gland", Cancer Res, 56, pp.1970~1973 (1996)
37. Franks, S, "Comparative pharmacology of oestrogens and catechol oestrogens: actions on the immature rat uterus in vivo and in vitro", J. Endocrinol, 94, pp.91~98 (1982)
38. Van Aswegen, C. H, "Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers", J. Steroid Biochem, 32, pp.485~492 (1989)
39. Spink, D. C, "Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells", Chem. Res. Toxicol, 14, pp.572~581 (2001)
40. Yamazaki, H, "Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes", Chem. Res. Toxicol, 11, pp.659~665 (1998)
41. Zhang, F, "Synthesis of the equine estrogen metabolites 2-hydroxyequilin and 2-hydroxyequilenin", Chem. Res. Toxicol, 12, pp.200~203 (1999)
42. Roy, D, "Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta- naphthoflavone-inducible cytochrome P450 IA family", Arch. Biochem. Biophys, 296, pp.450~456 (1992)
43. Markides, C. S, "Concentration dependence of prooxidant and antioxidant properties of catecholestrogens", Arch. Biochem. Biophys, 360, pp.105~112 (1998)
44. Roy, D, "Estrogen, DNA damage and mutations", Mutat. Res, 424, pp.107~115 (1999)
45. Rajapakse, N, "Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites", Environ. Mol. Mutagen, 45, pp.397~404 (2005)
46. Hobkirk,R, "Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles", Can. J. Biochem. Cell Biol, 63, pp.1127~1144 (1985)
47. Roy, A. K, "Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes", Proc. Soc. Exp. Biol. Med, 199, pp.265~272 (1992)
48. Ball, P, "Formation, metabolism, and physiologic importance of catecholestrogens", Am. J. Obstet. Gynecol, 163, pp.2163~2170 (1990)
49. Merriam, G. R, "Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors", Steroids, 36, pp.1~11 (1980)
50. Yue, T. L, "2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression", Mol. Pharmacol, 51, pp.951~962 (1997)
51. Schumacher, G, "The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors", J. Cancer Res. Clin. Oncol, 127, pp.405~410 (2001)
52. Schumacher, G, "Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines", Clin. Cancer Res, 5, pp.493~499 (1999)
53. Gubish, E. R, "2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate", Cancer Metastasis Rev, 19, pp.173~179 (2000)
54. Yao, J, "Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol- O-methyltransferase", Chem. Res. Toxicol, 16, pp.668~675 (2003)
55. Yao, J, "Inhibition of cellular enzymes by equine catechol estrogens in human breast cancer cells: specificity for glutathione S-transferase P1-1", Chem. Res. Toxicol, 15, pp.935~942 (2002)
56. Chang, M, "Structural and functional consequences of inactivation of human glutathione S-transferase P1-1 mediated by the catechol metabolite of equine estrogens, 4-hydroxyequilenin", Biochemistry, 40, pp.4811~4820 (2001)
57. Li, Y, "Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-Omethyltransferase", Chem. Res. Toxicol, 17, pp.512~520 (2004)
58. Loriaux, D. L, "Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy", J. Clin. Endocrinol. Metab, 35, pp.887~891 (1972)
59. Ruder, H. J, "Estrone sulfate: production rate and metabolism in man", J. Clin. Invest, 51, pp.1020~1033 (1972)
60. Carlstrom, K, "Metabolism of estrone sulfate in endometriotic tissue and in uterine endometrium in proliferative and secretory cycle phase", Feril. Steril, 49, pp.229~233 (1988)
61. Santen, R. J, "Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways", Ann. N. Y. Acad. Sci, 464, pp.126~137 (1986)
62. Zhu, B. T, "Metabolic deglucuronidation and demethylation of estrogen conjugates as a source of parent estrogens and catecholestrogen metabolites in Syrian hamster kidney, a target organ of estrogen- induced tumorigenesis", Toxicol. Appl. Pharmacol, 136, pp.186~193 (1996)
63. Walaszek, Z, "Potential use of D-glucaric acid derivatives in cancer prevention", Cancer Lett, 54, pp.1~8 (1990)
64. Watanabe, K, "Comparison of cytochrome P-450 species which catalyze the hydroxylations of the aromatic ring of estradiol and estradiol 17-sulfate", J. Steroid Biochem. Mol. Biol, 38, pp.737~743 (1991)
65. Purohit, A, "Regulation and inhibition of steroid sulfatase activity in breast cancer", Ann. N. Y. Acad. Sci, 784, pp.40~49 (1996)
66. Duncan, L, "Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer", Cancer Res, 53, pp.298~303 (1993)
67. Bjornstrom, L, "Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes", Mol. Endocrinol, 19, pp.833~842 (2005)
68. Marino, M, "Estrogen signaling multiple pathways to impact gene transcription", Curr. Genomics, 7, pp.497~508 (2006)
69. Safe, S, "Non-classical genomic estrogen receptor (ER)", specificity protein and ER, J. Mol. Endocrinol, pp.2008, 41[DOI]
70. Levin, E. R, "Cellular functions of plasma membrane estrogen receptors", Steroids, 67, pp.471~475 (2002)
71. Stoica, G. E, "Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2", PI 3-K, Oncogene, pp.2003, 22[DOI]
72. Levin, E. R, "Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor", Mol. Endocrinol, 17, pp.309~317 (2003)
73. Liao, J. K, "Cross-coupling between the oestrogen receptor and phosphoinositide 3-kinase", Biochem. Soc. Trans, 31, pp.66~70 (2003)
74. Chen, J. Q, "Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis", Ann. N. Y. Acad. Sci, 1028, pp.258~272 (2004)
75. Chen, J. Q, "Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells", Am. J. Physiol. Endocrinol. Metab, 286, pp.E1011~E1022 (2004)
76. Demonacos, C. V, "Mitochondrial genes as sites of primary action of steroid hormones", Steroids, 61, pp.226~232 (1996)
77. Zhu, B. T, "Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding", Endocrinology, 147, pp.4132~4150 (2006)
78. Vincent, T. L, "An evolutionary model for initiation, promotion, and progression in carcinogenesis", Int. J. Oncol, 32, pp.729~737 (2008)
79. Lavigne, J. A, "The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol- treated MCF-7 cells", Cancer Res, 61, pp.7488~7494 (2001)
80. Banerjee, S. K, "Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens", Mutat. Res, 311, pp.191~197 (1994)
81. Valko, M, "Role of oxygen radicals in DNA damage and cancer incidence", Mol. Cell. Biochem, 266, pp.37~56 (2004)
82. Chen, Z. H, "4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NF-kappaB and ERK", MAPK, 2005, pp.208, 46~56
83. Cavalieri, E, "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention", Biochim. Biophys. Acta, 1766, pp.63~78 (2006)
84. Saeed, M, "Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone", Implications for mutagenic activity. Steroids, 70, pp.29~35 (2005)
85. Zhao, Z, "Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol", Chem. Res. Toxicol, 19, pp.475~479 (2006)
86. Saeed, M, "Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol", Int. J. Cancer, 120, pp.1821~1824 (2007)
87. Zahid, M, "The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity", Chem. Res. Toxicol, 19, pp.164~172 (2006)
88. Embrechts, J, "Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry", J. Am. Sco. Mass Spectr, 14, pp.482~491 (2003)
89. Liu, X, "Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha", Chem. Res. Toxicol, 15, pp.512~519 (2002)
90. Chen, Y, "A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines", Chem. Res. Toxicol, 13, pp.342~350 (2000)
91. Zhang, F, "Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases", Chem. Res. Toxicol, 14, pp.1654~1659 (2001)
92. Okahashi, Y, "Quantitative detection of 4-hydroxyequilenin- DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody", Nucleic Acids Res, 38, pp.e133~ (2010)
93. Ozcagli, E, "Assessment of DNA damage in postmenopausal women under hormone replacement therapy", Maturitas, 51, pp.280~285 (2005)
94. Kamata, H, "Redox regulation of cellular signalling", Cell Signal, 11, pp.1~14 (1999)
95. Sauer, H, "Reactive oxygen species as intracellular messengers during cell growth and differentiation", Cell Physiol. Biochem, 11, pp.173~186 (2001)
96. Circu, M. L, "Reactive oxygen species, cellular redox systems, and apoptosis", Free Radic. Biol. Med, 48, pp.749~762 (2010)
97. Surh, Y.-J, "Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention with Anti-Inflammatory and Antioxidative Phytochemicals", J. Nutr, 135, pp.2993S~3001S (2005)
98. Roy, D, "Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers", J. Toxicol. Environ. Health B. Crit. Rev, 10, pp.235~257 (2007)
99. Foster, J. S, "Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function", Mol. Cell. Biol, 21, pp.794~810 (2001)
100. Cui, Y, "Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance", Cancer Res, 66, pp.5950~5959 (2006)
101. Weinstein-Oppenheimer, C. R, "The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line", Cancer Biol. Ther, 1, pp.256~262 (2002)
102. Adler, V, "Regulation of JNK signaling by GSTp", EMBO J, 18, pp.1321~1334 (1999)
103. Kar, S, "PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1", 2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo, 2006, pp.5, 1511~1519
104. Banerjee, S, "17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway", Biochem. Biophys. Res. Commun, 300, pp.209~215 (2003)
105. Lee, Y. R, "Up-regulation of PI3K", Akt signaling by 17beta-estradiol through activation of estrogen receptor- alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells, 2005, pp.336, 1221~1226
106. Rockhill, B, "Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention", J. Natl. Cancer Inst, 93, pp.358~366 (2001)
107. Cavalieri, E. L, "Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators", Proc. Natl. Acad. Sci. U. S. A, 94, pp.10937~10942 (1997)
108. Yager, J. D, "Molecular mechanisms of estrogen carcinogenesis", Annu. Rev. Pharmacol. Toxicol, 36, pp.203~232 (1996)
109. Parl, F. F, "Estrogen metabolism and breast cancer: a risk model", Ann. N. Y. Acad. Sci, 1155, pp.68~75 (2009)
110. Bocchinfuso, W. P, "A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor- alpha", Cancer Res, 59, pp.1869~1876 (1999)

관련 논문AI추천